Favourable risk factor trends and improvements in therapy each explain about half the substantial decrease in coronary heart disease (CHD) mortality that has occurred in Ontario in recent years.
A lenient approach to heart rate control in atrial fibrillation (AF) is just as effective as the strict approach generally recommended in guidelines, Dutch researchers have found.
A major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization.